BD to build $200M facility in Spain for pre-filled drug delivery device manufacturing

By Sean Whooley | May 18, 2021

BDlogoupdated BD (NYSE:BDX) announced today that it will build a more than $200 million drug delivery device manufacturing facility in Spain.

The approximately $201.5 million (€165 million) high-tech manufacturing facility in Zaragoza, Spain, is expected to create up to 600 jobs by 2030, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].